Eye Care Blog
Adie’s Tonic Pupil: Causes, Adaptation, and Associated Conditions
Adie’s Tonic Pupil, also known as Adie’s Syndrome or Holmes-Adie Syndrome, is a rare neurological condition that primarily affects the eye's response to light and accommodation (focusing on near objects). Typically, it presents in one eye, though both eyes can be...
Why My Vision Is Getting Worse: What Causes More Myopia in Adults?
Have you noticed your vision getting blurrier, even with your glasses or contacts? You’re not alone. Many adults experience increased myopia, also known as nearsightedness, over time. But what causes this change in adults? Let’s look at the common reasons—explained...
Understanding Astigmatism: Causes, Treatments, and a Glimpse at Keratoconus
Astigmatism is one of the most common refractive errors of the eye, affecting millions worldwide. Despite its prevalence, many people are unsure what astigmatism actually is or how it impacts vision. What Is Astigmatism? Astigmatism occurs when the cornea (the...
Could Your Weight Loss Medication Affect Your Vision? Understanding Semaglutides and the Risk of NAION
Semaglutides are a group of medications that have become very popular in recent years, especially for helping with weight loss and managing type 2 diabetes. You may have heard of them by their brand names, like Ozempic, Wegovy, and Rybelsus. While these medications...
Part 3: Who Can Benefit from Lumithera Valeda Treatment?
Lumithera Valeda is an excellent treatment option for individuals in the early to intermediate stages of dry macular degeneration. If you’ve experienced gradual vision loss, difficulty reading, or a decrease in your central vision, this light therapy may help slow the...
Part 2: How Lumithera Valeda Works and the Treatment Process
The Lumithera Valeda treatment uses photobiomodulation therapy to deliver low-level light to the retina, which stimulates mitochondrial activity in retinal cells. This process helps to reduce oxidative stress and inflammation, two major contributors to the progression...
Part 1: FDA Approval of Lumithera Valeda for Dry Macular Degeneration at Burman and Zuckerbrod Ophthalmology
Burman and Zuckerbrod Ophthalmology is proud to announce that we’re one of only 14 practices nationwide offering the groundbreaking Lumithera Valeda treatment for dry macular degeneration (AMD). Recently approved by the FDA, this innovative therapy manages a condition...
How the Valeda Lumithera Device Combines PBM with the Fight Against Dry Macular Degeneration
The Valeda Lumithera device is one of the first treatments specifically designed to combine photobiomodulation (PBM) therapy with the treatment of dry macular degeneration (AMD). This innovative, non-invasive device uses light-based technology to target the underlying...